Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease have?
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease has 22 citations in the OpenAlex counts ScholarIQ stores.
When was Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease published?
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease has 2025 year in the ScholarIQ index.
What is the open-access status of Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease?
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease has hybrid oa status in the ScholarIQ index.
What is the DOI of Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease?
The DOI for Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease is on the source record.
What is the PMID of Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease?
The PMID for Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease is on the source record.
What is the OpenAlex record for Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease?
The OpenAlex for Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease is on the source record.